In the next step, we attempted to identify a miR that has the most interactions with the studied oncogenes, i.e., MMP2, CD44, CDK6, CDK4, CCND1, RAF1, MAP2K1, MET, SRC, and CD274, that have pivotal roles in migration, stemness, cell cycle, and tumor development. The gene discussed is SRC; the disease is neoplasm.